\BOOKMARK [0][-]{part.1}{I Ter\340pia Cel\267lular}{}% 1
\BOOKMARK [1][-]{section.1}{Embrionic Stem Cells}{part.1}% 2
\BOOKMARK [2][-]{subsection.1.1}{Stem Cells}{section.1}% 3
\BOOKMARK [2][-]{subsection.1.2}{Blastocist pre-implantacional}{section.1}% 4
\BOOKMARK [2][-]{subsection.1.3}{Obtenci\363 de c\350l\267lules mare embrion\340ries}{section.1}% 5
\BOOKMARK [2][-]{subsection.1.4}{Marcadors}{section.1}% 6
\BOOKMARK [2][-]{subsection.1.5}{Manteniment de la pluripot\350ncia}{section.1}% 7
\BOOKMARK [1][-]{section.2}{Adult Stem Cells}{part.1}% 8
\BOOKMARK [2][-]{subsection.2.1}{C\350l\267lules mare hematopoi\350tiques}{section.2}% 9
\BOOKMARK [2][-]{subsection.2.2}{C\350l\267lules mare mesenquimals}{section.2}% 10
\BOOKMARK [1][-]{section.3}{Ter\340pia cel\267lular per malalties coron\340ries}{part.1}% 11
\BOOKMARK [2][-]{subsection.3.1}{Infart de miocardi}{section.3}% 12
\BOOKMARK [2][-]{subsection.3.2}{Estrat\350gies de ter\340pia}{section.3}% 13
\BOOKMARK [1][-]{section.4}{induced Pluripotent Stem Cells}{part.1}% 14
\BOOKMARK [2][-]{subsection.4.1}{C\350l\267lules som\340tiques vs ESC}{section.4}% 15
\BOOKMARK [2][-]{subsection.4.2}{Reprogramaci\363 cel\267lular}{section.4}% 16
\BOOKMARK [2][-]{subsection.4.3}{M\350todes}{section.4}% 17
\BOOKMARK [2][-]{subsection.4.4}{Caracteritzaci\363 de la pluripot\350ncia}{section.4}% 18
\BOOKMARK [2][-]{subsection.4.5}{Bancs de c\350l\267lules}{section.4}% 19
\BOOKMARK [2][-]{subsection.4.6}{\332s d'iPSC}{section.4}% 20
\BOOKMARK [1][-]{section.5}{C\350l\267lules mare neurals}{part.1}% 21
\BOOKMARK [0][-]{part.2}{II Ter\340pia G\350nica}{}% 22
\BOOKMARK [0][-]{section*.1}{Refer\350ncies}{}% 23
